Posted by Michael Wonder on 05 Aug 2015
CADTH is hosting a series of lectures by prominent scholars and opinion leaders to share their perspectives on some of ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\1 \7 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \ \P \H \A \R \M \A \C \space \i \n \v \i \t \e \s \space \p \r \o \p \o \s \a \l \s \space \f \o \r \space \t \h \e \space \s \u \p \p \l \y \space \o \f \space \c \o \n \t \r \a \c \e \p \t \i \v \e \space \i \m \p \l \a \n \t \s \space \i \n \space \N \e \w \space \Z \e \a \l \a \n \d \. " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
A drug used to treat women with the form of cancer that led Angelina Jolie to have her ovaries removed has been ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\T \h \e \space \P \B \A \C \space \w \i \l \l \space \c \o \n \s \i \d \e \r \space \5 \3 \space \s \u \b \m \i \s \s \i \o \n \s \space \( \3 \1 \m \a \j \o \r \space \& \space \2 \2 \space \m \i \n \o \r \) \space \a \t \space \i \t \s \space \n \e \x \t \space \s \c \h \e \d \u \l \e \d \space \m \e \e \t \i \n \g \space \i \n \space \M \a \r \c \h \. \ " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
As PBAC Chair I am deeply concerned by Alexion’s response to the Minister’s approval of funding for Soliris for the ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Committees of the UK National Institute for Health and Care Excellence (NICE) are being encouraged to be more favourable to ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
NICE has published final guidance recommending ustekinumab (Stelara) as a treatment option for psoriatic arthritis in certain circumstances. ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\1 \7 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \ \G \S \K \space \t \o \d \a \y \space \a \n \n \o \u \n \c \e \d \space \t \h \a \t \space \I \n \c \r \u \s \e \ \E \l \l \i \p \t \a \ \( \u \m \e \c \l \i \d \i \n \i \u \m \space \b \r \o \m \i \d \e \) \space \h \a \s \space \r \e \c \e \i \v \e \d \space \m \a \r \k \e \t \space \a \u \t \h \o \r \i \s \a \t \i \o \n \space \i \n \space \C \a \n \a \d \a \space \f \o \r \space \t \h \e \space \l \o \n \g \- \t \e \r \m \space \o \n \c \e \- \d \a \i \l \y \space \m \a \i \n \t \e \n \a \n \c \e " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\1 \8 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \ \P \H \A \R \M \A \C \space \i \s \space \s \e \e \k \i \n \g \space \f \e \e \d \b \a \c \k \space \o \n \space \t \h \e \space \c \r \i \t \e \r \i \a \space \i \t \space \u \s \e \s \space \t \o \space \m \a \k \e \space \d \e \c \i \s \i \o \n \s \. \space \Y \o \u \space \c \a \n \space \h \a \v \e \space \y \o \u \r \space \s \a \y " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\4 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \space \T \h \e \space \M \A \E \S \T \r \O \space \d \a \t \a \b \a \s \e \space \i \s \space \n \o \w \space \h \o \u \s \e \d \space \o \n \space \a \space \l \o \c \a \l \space \s \e \r \v \e \r \. \space \S \u \b \s \c \r \i \b \e \r \s \space \s \h \o \u \l \d \space \n \o \t \i \c \e \space \a \space \s \i \g \n \i \f \i \c \a \n \t \ \i \m \p \r \o \v \e \m \e \n \t \space \i \n " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
NICE, the healthcare guidance body, has issued new draft guidance not recommending nintedanib (also known as Vargatef) for the treatment ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
22 May 2014 - Protalix BioTherapeutics, Inc. announced today that the Australian Therapeutic Goods Administration (TGA) has granted regulatory approval to Elelyso (taliglucerase alfa) for long-term enzyme ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
President Barack Obama, prominent cancer doctors and health insurers are all warning about the need to control the surging prices ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Women with HER2-positive metastatic breast cancer in British Columbiawill now be able to access a new treatment option through the BC ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Germany’s IQWiG has concluded that Eisai’s breast cancer drug Halaven (erbulin mesylate) does indeed offer a benefit over other comparators on ...
Read more →